BOARD OF DIRECTORS

Amit M. Patel has over twenty years of healthcare industry experience with publicly-traded, private equity-backed, and start-up companies in the capacity of executive, board member, advisor, and investor.

Amit has been involved with Azurity Pharmaceuticals since 2018 in multiple capacities including board member, CEO (2020-2022), and Executive Chairman. Previously, Amit was SVP & President of Dosage Form Solutions at Capsugel, a KKR portfolio company (purchased from Pfizer in 2011 and sold to Lonza in 2017) that provided products and services to pharmaceutical and nutritional companies. Prior to Capsugel, he worked at Dr. Reddy’s Laboratories, Inc., a publicly-traded, global specialty-generic pharmaceutical company, where he held positions of EVP & Head, North America, and SVP & Head, Global Corporate Development & Strategic Planning. Earlier, Amit was VP, Corporate Development, at CTIS, Inc., and Co-founder & CEO of MedOnTime, Inc. (acquired by CTIS), both of which were healthcare information technology companies. He started his career as a consultant with Marakon Associates, a strategy consulting firm.

Amit holds an M.B.A. degree from Harvard Business School, a B.S. degree in Economics from the Wharton School of Business, University of Pennsylvania, and a B.A.S. degree in Systems Engineering from the Moore School of Engineering, University of Pennsylvania.